NeuCyte, Inc.

CNS drug discovery company. NeuCyte, Inc. is bridging the gap in neuroscience that exists between animal and human clinical studies by developing human induced pluripotent stem cell-based platforms for drug discovery. Our SynFire platform is established with proprietary technology to derive human iPSC brain cells that is both isogenic and modular enabling facilitating mimicry of the cellular complexity of the brain, enabling disease modeling, phenotypic drug discovery, target identification, and compound efficacy studies. The platform translates to an accelerated lead drug identification and optimization process, more reliable drug efficacy, and improved predictive neurotoxicity potential.